0

Journal Articles

in Drug Therapy
 301-320 of 342 Articles
Editorial | 
Gregory Simon, MD, MPH
JAMA. 2001;286(23):3003-3004. doi:10.1001/jama.286.23.3003.

Original Contribution |  FREE
Glenn M. Chertow, MD, MPH; Joshua Lee, MD; Gilad J. Kuperman, MD; et al.
JAMA. 2001;286(22):2839-2844. doi:10.1001/jama.286.22.2839.

Review |  FREE
Kathryn A. Phillips, PhD; David L. Veenstra, PhD, PharmD; Eyal Oren, BA; et al.
JAMA. 2001;286(18):2270-2279. doi:10.1001/jama.286.18.2270.

Original Contribution |  FREE
Brendan B. McCormick, MD; George Tomlinson, PhD; Patrick Brill-Edwards, MD; et al.
JAMA. 2001;286(16):1994-1999. doi:10.1001/jama.286.16.1994.

Clinical Crossroads | 
David W. Bates, MD, MSc
JAMA. 2001;285(24):3134-3140. doi:10.1001/jama.285.24.3134.

The Rational Clinical Examination | 
Alan R. Salkind, MD; Paul G. Cuddy, PharmD; John W. Foxworth, PharmD
JAMA. 2001;285(19):2498-2505. doi:10.1001/jama.285.19.2498.

Medical News and Perspectives | 
JAMA. 2001;285(17):2181-2182. doi:10.1001/jama.285.17.2181.

Original Contribution |  FREE
Rainu Kaushal, MD, MPH; David W. Bates, MD, MSc; Christopher Landrigan, MD, MPH; et al.
JAMA. 2001;285(16):2114-2120. doi:10.1001/jama.285.16.2114.

Research Opportunities for Specific Diseases and Disorders |  FREE
Gail H. Cassell, PhD; John Mekalanos, PhD
JAMA. 2001;285(5):601-605. doi:10.1001/jama.285.5.601.

Commentary | 
Raymond L. Woosley, MD, PhD
JAMA. 2000;284(23):3047-3049. doi:10.1001/jama.284.23.3047.

msJAMA |  FREE
JAMA. 2000;284(17):2239-2240. doi:10.1001/jama.284.17.2239.

Medical News and Perspectives | 
JAMA. 2000;284(10):1229. doi:10.1001/jama.284.10.1229.

The World in Medicine | 
JAMA. 2000;284(2):169. doi:10.1001/jama.284.2.169.

From the Food and Drug Administration | 
JAMA. 2000;283(13):1679. doi:10.1001/jama.283.13.1679.

Original Contribution |  FREE
Julie Magno Zito, PhD; Daniel J. Safer, MD; Susan dosReis, PhD; et al.
JAMA. 2000;283(8):1025-1030. doi:10.1001/jama.283.8.1025.

Review |  FREE
Ashley Wazana, MD
JAMA. 2000;283(3):373-380. doi:10.1001/jama.283.3.373.

Editorial | 
Martin Markowitz, MD
JAMA. 2000;283(2):250-251. doi:10.1001/jama.283.2.250.

Editorial | 
Walter L. Peterson, MD; Byron Cryer, MD
JAMA. 1999;282(20):1961-1963. doi:10.1001/jama.282.20.1961.

Controversies | 
Bruce M. Psaty, MD, PhD; Noel S. Weiss, MD, DrPH; Curt D. Furberg, MD, PhD; et al.
JAMA. 1999;282(8):786-790. doi:10.1001/jama.282.8.786.

Caring for the Critically Ill Patient |  FREE
Lucian L. Leape, MD; David J. Cullen, MD; Margaret Dempsey Clapp, MS, RPh; et al.
JAMA. 1999;282(3):267-270. doi:10.1001/jama.282.3.267.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  | 
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Original Investigation  | 
Dietary and Supplemental Calcium Intake and Cardiovascular Disease Mortality:  The National Institutes of Health–AARP Diet and Health Study
Qian Xiao, PhD; Rachel A. Murphy, PhD; Denise K. Houston, PhD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
JAMA Internal Medicine
Research Letters  | 
Trends in On-label and Off-label Modafinil Use in a Nationally Representative Sample
Renée A. Peñaloza, MS; Urmimala Sarkar, MD, MPH; David M. Claman, MD; et al.